₩12,790.00 ($9.51)

+10.00 (+0.08%)

Weekly Expected Move ±2.3%

₩12211 ₩12501 ₩12790 ₩13079 ₩13369

KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 32 · ₩70.2B mcap · 3M float · 1.09% daily turnover

Analysis Technicals Weather Peers

Revenue

$160.1B -6.8% ▼

5Y CAGR: +5.1%

Gross Profit

$26.1B -27.4% ▼

5Y CAGR: -1.3%

Operating Income

$3.6B -67.1% ▼

5Y CAGR: -13.9%

Net Income

-$2.9B -133.2% ▼

EPS (Diluted)

$-526.16 -133.2% ▼

EBITDA

$19.3B -38.2% ▼

5Y CAGR: -0.6%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$142.2B	$156.0B	$160.4B	$171.8B	$160.1B
YoY Growth	+14.2%	+9.7%	+2.8%	+7.1%	-6.8%
Cost of Revenue	$128.9B	$139.3B	$155.3B	$135.8B	$134.0B
Gross Profit	$13.3B	$16.8B	$5.0B	$35.9B	$26.1B
Gross Margin	9.4%	10.8%	3.1%	20.9%	16.3%
R&D Expenses	$11.5B	$15.4B	$12.7B	$13.5B	$3.4B
SG&A Expenses	$6.9B	$9.1B	$12.5B	$5.5B	$19.1B
Operating Expenses	$24.7B	$31.6B	$25.2B	$25.0B	$22.5B
Operating Income	-$9.8B	-$14.8B	-$20.2B	$11.0B	$3.6B
Operating Margin	-6.9%	-9.5%	-12.6%	6.4%	2.3%
Interest Expense	$1.9B	$2.9B	$5.0B	$5.3B	$5.6B
Income Before Tax	-$13.4B	-$18.6B	-$24.2B	$9.2B	-$3.0B
Tax Expense	-$6.8B	-$1.9B	-$4M	$515M	-$78M
Net Income	-$6.6B	-$16.7B	-$24.2B	$8.7B	-$2.9B
Net Margin	-4.6%	-10.7%	-15.1%	5.1%	-1.8%
EPS (Diluted)	$-1198.81	$-3044.61	$-4409.90	$1586.02	$-526.16
EBITDA	$5.6B	$2.3B	-$1.6B	$31.2B	$19.3B
Shares Outstanding	5M	5M	5M	5M	5M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$43.9B	$31.4B	$42.5B	$41.2B	$34.1B	$42.2B	$40.7B	$41.1B
Cost of Revenue	$34.9B	$25.2B	$34.0B	$32.0B	$28.2B	$39.7B	$36.2B	$40.3B
Gross Profit	$9.0B	$6.2B	$8.5B	$9.2B	$5.9B	$2.5B	$4.5B	$751M
Gross Margin	20.5%	19.8%	20.0%	22.3%	17.2%	6.0%	11.0%	1.8%
R&D Expenses	$3.6B	$3.2B	$3.2B	$3.1B	$3.9B	-$6.8B	$984M	$0
SG&A Expenses	$6.4B	$1.3B	$3.2B	$1.6B	$1.7B	$1.7B	$1.9B	$1.7B
Operating Expenses	$6.4B	$6.0B	$6.4B	$6.3B	$7.3B	$2.7B	$6.2B	$5.8B
Operating Income	$2.6B	$209M	$2.1B	$2.9B	-$1.5B	$109M	-$1.7B	-$5.0B
Operating Margin	5.9%	0.7%	4.9%	7.0%	-4.3%	0.3%	-4.2%	-12.2%
Interest Expense	$1.3B	$1.2B	$1.3B	$1.4B	$1.4B	$1.4B	$1.5B	$1.3B
Income Before Tax	$129M	$1.5B	$861M	-$651M	-$2.2B	-$1.0B	-$2.0B	-$5.7B
Tax Expense	-$156M	$326M	-$39M	-$171M	$28M	$104M	-$10M	-$311M
Net Income	$285M	$1.2B	$900M	-$480M	-$2.2B	-$1.1B	-$2.0B	-$5.4B
Net Margin	0.6%	3.8%	2.1%	-1.2%	-6.4%	-2.7%	-5.0%	-13.2%
EPS (Diluted)	$51.95	$215.04	$164.06	$-87.00	$-397.00	$-205.70	$-369.85	$-985.24
EBITDA	$2.6B	$6.7B	$2.1B	$4.7B	$3.2B	$4.1B	$2.3B	-$1.0B
Shares Outstanding	5M	5M	5M	6M	5M	5M	5M	5M

063160.KS KSC